FMO5 and cancer: Thus, upregulation of NAD(P)H oxidases likely confers an increased metastatic potential through enhanced levels of endogenous ROS in aggressive cancer cells, but subjects the same cells to increased susceptibility to oxidant toxicity through NAD(P)H oxidases-mediated O2•− burst.